Massive cancer gene mapping project aims to unlock new treatments
NCT ID NCT05142033
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will analyze the genes of 25,000 adults who have cancer or are at risk for it. Researchers will use advanced testing to find genetic changes linked to cancer and track health records over time. The goal is to learn more about cancer biology and discover new ways to personalize treatment. No experimental therapies are given—this is a research-only study.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Avera Cancer Institute
RECRUITINGSioux Falls, South Dakota, 57105, United States
-
Avera Cancer Institute - Aberdeen
RECRUITINGAberdeen, South Dakota, 57401, United States
-
Avera Cancer Institute - Marshall
RECRUITINGMarshall, Minnesota, 56258, United States
-
Avera Cancer Institute - Mitchell
RECRUITINGMitchell, South Dakota, 57301, United States
-
Avera Cancer Institute - Pierre
RECRUITINGPierre, South Dakota, 57501, United States
-
Avera Cancer Institute - Yankton
RECRUITINGYankton, South Dakota, 57078, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- A good Night's sleep: could a simple program ease Cancer's toll on rest?
- Can a simple CT scan catch lung cancer earlier in kuwait?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could sitting up make radiation therapy more comfortable?